Mikako Ishijima
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Safety and effectiveness of pirfenidone combined with carboplatin-based chemotherapy in patients with idiopathic pulmonary fibrosis and non-small cell lung cancer: A retrospective cohort study.
Journal: Thoracic cancer
Published: September 03, 2020
Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune-related adverse effect: A case report.
Journal: Thoracic cancer
Published: February 16, 2019
A case of meningoencephalitis associated with pembrolizumab treated for squamous cell lung cancer
Journal: Rinsho shinkeigaku = Clinical neurology
Published: February 01, 2019
Two cases of response to pembrolizumab in epidermal growth factor receptor mutated lung adenocarcinoma patients with programmed death-ligand 1 overexpression.
Journal: Annals of translational medicine
Published: January 01, 2019
Post-progression survival after cessation of treatment with nivolumab for advanced non-small cell lung cancer: A retrospective study.
Journal: PloS one
Published: April 22, 2018
Radiation Pneumonitis with Eosinophilic Alveolitis in a Lung Cancer Patient.
Journal: Internal medicine (Tokyo, Japan)
Published: December 28, 2017
Case series of pleomorphic carcinomas of the lung treated with nivolumab.
Journal: Thoracic cancer
Published: June 30, 2017
Vitiligo in a patient with lung adenocarcinoma treated with nivolumab: A case report.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 27, 2016
Last Updated: 09/26/2026